Mar 2020 - Present
AeroLeads people directory · profile
Howard Urnovitz Email & Phone Number
Founder - The Golden Age of Virology
at
FBB Biomed
LinkedIn matched
✓ Verified August 2026
3 data sources
Profile completeness 86%
Who is Howard Urnovitz? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Howard Urnovitz is listed as Founder - The Golden Age of Virology at FBB Biomed, based in United States. AeroLeads shows a matched LinkedIn profile for Howard Urnovitz.
Howard Urnovitz previously worked as Chief Executive Officer at Fbb Biomed and Founder, CEO, Director at Chronix Biomedical. Howard Urnovitz holds Doctor Of Philosophy - Phd, Microbiology And Immunology from University Of Michigan - Rackham Graduate School.
Company email context
Email format at FBB Biomed
This section adds company-level context without repeating Howard Urnovitz's masked contact details.
FBB Biomed
Review company-level records connected to Howard Urnovitz before choosing the right outreach path.
Profile bio
About Howard Urnovitz
The Golden Age of Virology reflects our dedication to advancing the field of virology and biotechnology, with a strong focus on genomic health. Our team has successfully integrated AI/ML analytics into our product development pipeline, enhancing our capabilities in genomics and medical device innovation. With a proven track record in commercialization, we have propelled multiple biomarkers into clinical practice, improving patient outcomes. The organization's leadership in intellectual property and next-generation sequencing continues to contribute to groundbreaking discoveries in the root causes of disease with clinical laboratory advancements.
Current workplace
Howard Urnovitz's current company
Company context helps verify the profile and gives searchers a useful next step.
5 roles
Howard Urnovitz work experience
A career timeline built from the work history available for this profile.
Founder, Ceo, Director
Chronix Biomedical
Publications:1. Schütz, Ekkehard, Mohammad R. Akbari, Julia Beck, Howard Urnovitz, William W. Zhang, Kirsten Bornemann-Kolatzki, William M. Mitchell, Robert K. Nam, and Steven A. Narod. "Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate Cancer." Clinical chemistry (2014): clinchem-2014.2. Beck, Julia, Howard B. Urnovitz, Joachim Riggert, Mario Clerici, and Ekkehard Schütz. "Profile of the circulating DNA in apparently healthy individuals." Clinical chemistry 55, no. 4 (2009): 730-738.3. Beck, Julia, Howard B. Urnovitz, William M. Mitchell, and Ekkehard Schütz. "Next generation sequencing of serum circulating nucleic acids from patients with invasive ductal breast cancer reveals differences to healthy and nonmalignant controls." Molecular Cancer Research 8, no. 3 (2010): 335-342.4. Beck, Julia, Howard B. Urnovitz, Marina Saresella, Domenico Caputo, Mario Clerici, William M. Mitchell, and Ekkehard Schütz. "Serum DNA motifs predict disease and clinical status in multiple sclerosis." The Journal of Molecular Diagnostics 12, no. 3 (2010): 312-319.5. Gordon, Paul MK, Ekkehard Schütz, Julia Beck, Howard B. Urnovitz, Catherine Graham, Renee Clark, Sandor Dudas et al. "Disease-specific motifs can be identified in circulating nucleic acids from live elk and cattle infected with transmissible spongiform encephalopathies." Nucleic acids research 37, no. 2 (2009): 550-556.6. Urnovitz, Howard B., James J. Tuite, Jean M. Higashida, and William H. Murphy. "RNAs in the sera of Persian Gulf War veterans have segments homologous to chromosome 22q11. 2." Clinical and diagnostic laboratory immunology 6, no. 3 (1999): 330-335.
Apr 2001 - Jun 2017
Founder, Chief Science Officer, Director
Director; Responsible Head for R/D for FDA licensed HIV Urine EIA and FDA licensed HIV Urine Western Blot Confirmation Test. Secured Venture Capital Financing, IPO, IP licensingPublications: 1. Urnovitz, Howard B., and William H. Murphy. "Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease." Clinical Microbiology Reviews 9.1 (1996): 72-99.2. Urnovitz, Howard B., Jerrilyn C. Sturge, and Toby D. Gottfried. "Increased sensitivity of HIV-1 antibody detection." Nature medicine 3.11 (1997): 1258-1258.3. Urnovitz, H. B., T. D. Gottfried, D. J. Robison, L. I. Lutwick, D. V. Lancers, L. Montagnier, M. Clerici, and G. M. Shearer. "HIV-1 antibody serum negativity with urine positivity." The Lancet 342, no. 8885 (1993): 1458-1459.4. Urnovitz, Howard B., Jerrilyn C. Sturge, Toby D. Gottfried, and William H. Murphy. "Urine antibody tests: new insights into the dynamics of HIV-1 infection." Clinical chemistry 45, no. 9 (1999): 1602-1613.5. Schnettler, R., P. Gessner, U. Zimmermann, G. A. Neil, and H. B. Urnovitz. "Increased efficiency of mammalian somatic cell hybrid production under microgravity conditions during ballistic rocket flight." (1989).6. Mazzoli, Sandra, Lucia Lopalco, Alessandra Salvi, Daria Trabattoni, Sergio Lo Caputo, Francesca Semplici, Mara Biasin et al. "Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons." Journal of Infectious Diseases 180, no. 3 (1999): 871-875.7. Stevens, Roy W., Aldona L. Baltch, Raymond P. Smith, Bruce J. McCreedy, Phyllis B. Michelsen, Lawrence H. Bopp, and Howard B. Urnovitz. "Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1-positive patients." Clinical and diagnostic laboratory immunology 6, no. 6 (1999): 783-786.
Jun 1988 - Mar 2001
Postdoctoral Researcher
Created the Pathology Department Hybridoma Lab. Discovery: IgA:IgM heteropolymers from hybrid hybridomas. Publication:Urnovitz, H. B., Y. Chang, M. Scott, J. Fleischman, and R. G. Lynch. IgA:IgM and IgA:IgA Hybrid Hybridomas Secrete Heteropolymeric Immunoglobulins That Are Polyvalent and Bi-Specific. J. Immunol. 140: 558-563, 1988.
Jul 1981 - Dec 1983
Post-Doctoral Fellow
Isolated idiotypic antibodies with anti-idiotype affinity chromatography.Lynch, R. G., Milburn, G. L., Urnovitz, H. B., Binion, S. B., Williams, K. R., & Mueller, A. (1983). The analysis of immunoregulatory mechanisms with myeloma, lymphoma and hybridoma cells. Prog Immunol, 719, 726.
Jun 1979 - Jun 1981
3 education records
Howard Urnovitz education
Doctor Of Philosophy - Phd, Microbiology And Immunology
University Of Michigan - Rackham Graduate School
Ms, Microbiology And Immunology
University Of Michigan - Rackham Graduate School
Bs, Honors College
University Of Michigan
FAQ
Frequently asked questions about Howard Urnovitz
Quick answers generated from the profile data available on this page.
What company does Howard Urnovitz work for?
Howard Urnovitz works for FBB Biomed.
What is Howard Urnovitz's role at FBB Biomed?
Howard Urnovitz is listed as Founder - The Golden Age of Virology at FBB Biomed.
Where is Howard Urnovitz based?
Howard Urnovitz is based in United States while working with FBB Biomed.
What companies has Howard Urnovitz worked for?
Howard Urnovitz has worked for Fbb Biomed, Chronix Biomedical, Calypte Biomedical, University Of Iowa, and Washington University School Of Medicine.
How can I contact Howard Urnovitz?
You can use AeroLeads to view verified contact signals for Howard Urnovitz at FBB Biomed, including work email, phone, and LinkedIn data when available.
What schools did Howard Urnovitz attend?
Howard Urnovitz holds Doctor Of Philosophy - Phd, Microbiology And Immunology from University Of Michigan - Rackham Graduate School.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial